Sarcoma treatment in the era of molecular medicine

Grunewald, Thomas G. P., Alonso, Marta, Avnet, Sofia, Banito, Ana, Burdach, Stefan, Cidre-Aranaz, Florencia, Di Pompo, Gemma, Distel, Martin, Dorado-Garcia, Heathcliff, Garcia-Castro, Javier, Gonzalez-Gonzalez, Laura, Grigoriadis, Agamemnon E., Kasan, Merve, Koelsche, Christian, Krumbholz, Manuela, Lecanda, Fernando, Lemma, Silvia, Longo, Dario L., Madrigal-Esquivel, Claudia, Morales-Molina, Alvaro, Musa, Julian, Ohmura, Shunya, Ory, Benjamin, Pereira-Silva, Miguel, Perut, Francesca, Rodriguez, Rene, Seeling, Carolin, Al Shaaili, Nada, Shaabani, Shabnam, Shiavone, Kristina, Sinha, Snehadri, Tomazou, Eleni M., Trautmann, Marcel, Vela, Maria, Versleijen-Jonkers, Yvonne M. H., Visgauss, Julia, Zalacain, Marta, Schober, Sebastian J., Lissat, Andrej, English, William R. ORCID: https://orcid.org/0000-0003-3024-2441, Baldini, Nicola and Heymann, Dominique (2020) Sarcoma treatment in the era of molecular medicine. EMBO Molecular Medicine, 12 (11). ISSN 1757-4676

Full text not available from this repository.

Abstract

Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers. Although constituting only 1% of all human malignancies, sarcomas represent the second most common type of solid tumors in children and adolescents and comprise an important group of secondary malignancies. More than 100 histological subtypes have been characterized to date, and many more are being discovered due to molecular profiling. Owing to their mostly aggressive biological behavior, relative rarity, and occurrence at virtually every anatomical site, many sarcoma subtypes are in particular difficult-to-treat categories. Current multimodal treatment concepts combine surgery, polychemotherapy (with/without local hyperthermia), irradiation, immunotherapy, and/or targeted therapeutics. Recent scientific advancements have enabled a more precise molecular characterization of sarcoma subtypes and revealed novel therapeutic targets and prognostic/predictive biomarkers. This review aims at providing a comprehensive overview of the latest advances in the molecular biology of sarcomas and their effects on clinical oncology; it is meant for a broad readership ranging from novices to experts in the field of sarcoma.

Item Type:	Article
Uncontrolled Keywords:	sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Depositing User:	LivePure Connector
Date Deposited:	15 Dec 2022 16:31
Last Modified:	19 Dec 2022 01:21
URI:	https://ueaeprints.uea.ac.uk/id/eprint/90229
DOI:	10.15252/emmm.201911131

Actions (login required)

View Item